$GCTKSep 2, 2026, 1:15 PMAI processed
GCTK: Lōkahi partners with SDSU to expand ai² Futures Lab asset sourcing
AI Summary
Glucotrack-operated Lōkahi Therapeutics (GCTK) announced a collaboration with San Diego State University's Fowler College of Business to expand its ai² Futures Lab network for identifying and evaluating overlooked or deprioritized therapeutic assets. In year one the program engaged 64 students and identified more than 45 potential assets, several of which advanced into active pipeline discussions, and Lōkahi says the partnership is intended to boost its sourcing and analytical capacity for capital-efficient pipeline development.
Positives
- Adds SDSU Fowler College to ai² Futures Lab, expanding academic asset origination network
- Program previously engaged 64 students and identified >45 potential assets, with several advancing into pipeline discussions
- ai² model described as capital-efficient pathway that could generate licensing, partnership, or acquisition opportunities
Negatives
- No financial terms, binding deals, or timeframes disclosed
- Identified assets are described as overlooked or deprioritized and remain early-stage with unproven clinical/commercial value
- Collaboration increases sourcing capacity but does not guarantee near-term revenue or clinical milestones